Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care IT services specialist Catamaran has earned a respected four-star ranking.
With that in mind, let's take a closer look at Catamaran and see what CAPS investors are saying about the stock right now.
Lisle, Ill. (1993)
Health care services
Chairman/CEO Mark Thierer
Cash / Debt
$311.4 million / $1.1 billion
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 95% of the 384 members who have rated Catamaran believe the stock will outperform the S&P 500 going forward.
Classic disruptor that has been successful. There is a lot to like in this business.
-Transparent business model is disruptive to the traditional PBM market.
-CTRX's technology is superior to competitors.
-Now that they are established in difficult customer segments (public-sector institutions and state Medicaid claims), there are high switching costs for customers to leave.
-Healthcare reform is putting a lot of pressure on Managed Care Organizations to take costs out of the system (which would reduce costs to the final consumers).
-The flood of generics into pharmaceuticals offers opportunity for PBM's to take additional costs out.
Reducing costs is a huge opportunity for Catamaran. Their fixed-price, transparent business model is aligned with the direction the industry appears to be heading. If they can upsell to larger clients, they could go from disruptor to the industry standard.
If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong four-star rating, Catamaran may not be your top choice.
We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
The article Why Catamaran Is Poised to Keep Sailing originally appeared on Fool.com.
Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends Catamaran and Express Scripts. The Motley Fool owns shares of Catamaran and Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.